Dynamics of Diabetes-Associated Autoantibodies in Young Children with Human Leukocyte Antigen-Conferred Risk of Type 1 Diabetes Recruited from the General Population

This study characterized the dynamics of islet cell antibodies (ICA), insulin antibodies (IAA), glutamic acid decarboxylase antibodies (GADA), and IA-2 antibodies (IA-2A) in 1006 children recruited from the general population due to human leukocyte antigen (HLA) DQB1-conferred risk for type 1 diabet...

Full description

Saved in:
Bibliographic Details
Published inThe journal of clinical endocrinology and metabolism Vol. 90; no. 5; pp. 2712 - 2717
Main Authors Kukko, M, Kimpimäki, T, Korhonen, S, Kupila, A, Simell, S, Veijola, R, Simell, T, Ilonen, J, Simell, O, Knip, M
Format Journal Article
LanguageEnglish
Published Bethesda, MD Endocrine Society 01.05.2005
Copyright by The Endocrine Society
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This study characterized the dynamics of islet cell antibodies (ICA), insulin antibodies (IAA), glutamic acid decarboxylase antibodies (GADA), and IA-2 antibodies (IA-2A) in 1006 children recruited from the general population due to human leukocyte antigen (HLA) DQB1-conferred risk for type 1 diabetes (T1D). By the age of 5 yr, 13.8% of the children had had one or more autoantibodies in at least one sample drawn at 3- to 12-month intervals from birth, whereas 6.1% had had one or more of the three autoantibodies to biochemically defined antigens in at least two consecutive samples. The cumulative frequencies of positivity for at least two antibodies ranged from 3.2–4.4%. Seventy-five children (7.5%) had at least once ICA, 83 (8.3%) had IAA, 46 (4.6%) had GADA, and 33 (3.3%) had IA-2A. IAA were transient more frequently than the other antibodies (P ≤ 0.03) and fluctuated between positivity and negativity more often than ICA (P = 0.001). The genetically high risk children were positive for each autoantibody reactivity more often (P ≤ 0.03) than the moderate risk subjects. Thirteen of the 1006 children (1.3%) presented with T1D by the age of 5 yr. The most sensitive predictors of T1D were ICA and IAA, whereas the most specific predictor was IA-2A. Positivity for at least two autoantibodies of IAA, GADA, and IA-2A had the highest positive predictive value for T1D (34%). We conclude that the frequency of various diabetes-associated autoantibodies increases at a relatively stable rate at least up to the age of 5 yr. Persistent positivity for two or more autoantibodies appears to reflect destructive progressive β-cell autoimmunity, whereas positivity for a single autoantibody may represent harmless nonprogressive or even regressive β-cell autoimmunity.
AbstractList This study characterized the dynamics of islet cell antibodies (ICA), insulin antibodies (IAA), glutamic acid decarboxylase antibodies (GADA), and IA-2 antibodies (IA-2A) in 1006 children recruited from the general population due to human leukocyte antigen (HLA) DQB1-conferred risk for type 1 diabetes (T1D). By the age of 5 yr, 13.8% of the children had had one or more autoantibodies in at least one sample drawn at 3- to 12-month intervals from birth, whereas 6.1% had had one or more of the three autoantibodies to biochemically defined antigens in at least two consecutive samples. The cumulative frequencies of positivity for at least two antibodies ranged from 3.2-4.4%. Seventy-five children (7.5%) had at least once ICA, 83 (8.3%) had IAA, 46 (4.6%) had GADA, and 33 (3.3%) had IA-2A. IAA were transient more frequently than the other antibodies (P < or = 0.03) and fluctuated between positivity and negativity more often than ICA (P = 0.001). The genetically high risk children were positive for each autoantibody reactivity more often (P < or = 0.03) than the moderate risk subjects. Thirteen of the 1006 children (1.3%) presented with T1D by the age of 5 yr. The most sensitive predictors of T1D were ICA and IAA, whereas the most specific predictor was IA-2A. Positivity for at least two autoantibodies of IAA, GADA, and IA-2A had the highest positive predictive value for T1D (34%). We conclude that the frequency of various diabetes-associated autoantibodies increases at a relatively stable rate at least up to the age of 5 yr. Persistent positivity for two or more autoantibodies appears to reflect destructive progressive beta-cell autoimmunity, whereas positivity for a single autoantibody may represent harmless nonprogressive or even regressive beta-cell autoimmunity.
This study characterized the dynamics of islet cell antibodies (ICA), insulin antibodies (IAA), glutamic acid decarboxylase antibodies (GADA), and IA-2 antibodies (IA-2A) in 1006 children recruited from the general population due to human leukocyte antigen (HLA) DQB1-conferred risk for type 1 diabetes (T1D). By the age of 5 yr, 13.8% of the children had had one or more autoantibodies in at least one sample drawn at 3- to 12-month intervals from birth, whereas 6.1% had had one or more of the three autoantibodies to biochemically defined antigens in at least two consecutive samples. The cumulative frequencies of positivity for at least two antibodies ranged from 3.2–4.4%. Seventy-five children (7.5%) had at least once ICA, 83 (8.3%) had IAA, 46 (4.6%) had GADA, and 33 (3.3%) had IA-2A. IAA were transient more frequently than the other antibodies (P ≤ 0.03) and fluctuated between positivity and negativity more often than ICA (P = 0.001). The genetically high risk children were positive for each autoantibody reactivity more often (P ≤ 0.03) than the moderate risk subjects. Thirteen of the 1006 children (1.3%) presented with T1D by the age of 5 yr. The most sensitive predictors of T1D were ICA and IAA, whereas the most specific predictor was IA-2A. Positivity for at least two autoantibodies of IAA, GADA, and IA-2A had the highest positive predictive value for T1D (34%). We conclude that the frequency of various diabetes-associated autoantibodies increases at a relatively stable rate at least up to the age of 5 yr. Persistent positivity for two or more autoantibodies appears to reflect destructive progressive β-cell autoimmunity, whereas positivity for a single autoantibody may represent harmless nonprogressive or even regressive β-cell autoimmunity.
This study characterized the dynamics of islet cell antibodies (ICA), insulin antibodies (IAA), glutamic acid decarboxylase antibodies (GADA), and IA-2 antibodies (IA-2A) in 1006 children recruited from the general population due to human leukocyte antigen (HLA) DQB1-conferred risk for type 1 diabetes (T1D). By the age of 5 yr, 13.8% of the children had had one or more autoantibodies in at least one sample drawn at 3- to 12-month intervals from birth, whereas 6.1% had had one or more of the three autoantibodies to biochemically defined antigens in at least two consecutive samples. The cumulative frequencies of positivity for at least two antibodies ranged from 3.2-4.4%. Seventy-five children (7.5%) had at least once ICA, 83 (8.3%) had IAA, 46 (4.6%) had GADA, and 33 (3.3%) had IA-2A. IAA were transient more frequently than the other antibodies (P less than or equal to 0.03) and fluctuated between positivity and negativity more often than ICA (P = 0.001). The genetically high risk children were positive for each autoantibody reactivity more often (P less than or equal to 0.03) than the moderate risk subjects. Thirteen of the 1006 children (1.3%) presented with T1D by the age of 5 yr. The most sensitive predictors of T1D were ICA and IAA, whereas the most specific predictor was IA-2A. Positivity for at least two autoantibodies of IAA, GADA, and IA-2A had the highest positive predictive value for T1D (34%). We conclude that the frequency of various diabetes-associated autoantibodies increases at a relatively stable rate at least up to the age of 5 yr. Persistent positivity for two or more autoantibodies appears to reflect destructive progressive beta -cell autoimmunity, whereas positivity for a single autoantibody may represent harmless nonprogressive or even regressive beta -cell autoimmunity.
This study characterized the dynamics of islet cell antibodies (ICA), insulin antibodies (IAA), glutamic acid decarboxylase antibodies (GADA), and IA-2 antibodies (IA-2A) in 1006 children recruited from the general population due to human leukocyte antigen (HLA) DQB1-conferred risk for type 1 diabetes (T1D). By the age of 5 yr, 13.8% of the children had had one or more autoantibodies in at least one sample drawn at 3- to 12-month intervals from birth, whereas 6.1% had had one or more of the three autoantibodies to biochemically defined antigens in at least two consecutive samples. The cumulative frequencies of positivity for at least two antibodies ranged from 3.2-4.4%. Seventy-five children (7.5%) had at least once ICA, 83 (8.3%) had IAA, 46 (4.6%) had GADA, and 33 (3.3%) had IA-2A. IAA were transient more frequently than the other antibodies (P &lt; or = 0.03) and fluctuated between positivity and negativity more often than ICA (P = 0.001). The genetically high risk children were positive for each autoantibody reactivity more often (P &lt; or = 0.03) than the moderate risk subjects. Thirteen of the 1006 children (1.3%) presented with T1D by the age of 5 yr. The most sensitive predictors of T1D were ICA and IAA, whereas the most specific predictor was IA-2A. Positivity for at least two autoantibodies of IAA, GADA, and IA-2A had the highest positive predictive value for T1D (34%). We conclude that the frequency of various diabetes-associated autoantibodies increases at a relatively stable rate at least up to the age of 5 yr. Persistent positivity for two or more autoantibodies appears to reflect destructive progressive beta-cell autoimmunity, whereas positivity for a single autoantibody may represent harmless nonprogressive or even regressive beta-cell autoimmunity.
Author Kimpimäki, T
Simell, O
Ilonen, J
Kukko, M
Korhonen, S
Knip, M
Simell, T
Kupila, A
Simell, S
Veijola, R
AuthorAffiliation Juvenile Diabetes Research Foundation Center for the Prevention of Type 1 Diabetes in Finland (M.K., T.K., S.K., A.K., S.S., R.V., T.S., J.I., O.S., M.K.) and Medical School, University of Tampere, and Department of Pediatrics, Tampere University Hospital (M.K., T.K., M.K.), FI-33014 Tampere, Finland; Department of Pediatrics, University of Oulu (S.K., R.V.), FI-90014 Oulu, Finland; Departments of Pediatrics (A.K., S.S., T.S., O.S.) and Virology (J.I.), University of Turku, FI-20520 Turku, Finland; and Hospital for Children and Adolescents, University of Helsinki (M.K.), FI-00029 Helsinki, Finland
AuthorAffiliation_xml – name: Juvenile Diabetes Research Foundation Center for the Prevention of Type 1 Diabetes in Finland (M.K., T.K., S.K., A.K., S.S., R.V., T.S., J.I., O.S., M.K.) and Medical School, University of Tampere, and Department of Pediatrics, Tampere University Hospital (M.K., T.K., M.K.), FI-33014 Tampere, Finland; Department of Pediatrics, University of Oulu (S.K., R.V.), FI-90014 Oulu, Finland; Departments of Pediatrics (A.K., S.S., T.S., O.S.) and Virology (J.I.), University of Turku, FI-20520 Turku, Finland; and Hospital for Children and Adolescents, University of Helsinki (M.K.), FI-00029 Helsinki, Finland
Author_xml – sequence: 1
  givenname: M
  surname: Kukko
  fullname: Kukko, M
– sequence: 2
  givenname: T
  surname: Kimpimäki
  fullname: Kimpimäki, T
– sequence: 3
  givenname: S
  surname: Korhonen
  fullname: Korhonen, S
– sequence: 4
  givenname: A
  surname: Kupila
  fullname: Kupila, A
– sequence: 5
  givenname: S
  surname: Simell
  fullname: Simell, S
– sequence: 6
  givenname: R
  surname: Veijola
  fullname: Veijola, R
– sequence: 7
  givenname: T
  surname: Simell
  fullname: Simell, T
– sequence: 8
  givenname: J
  surname: Ilonen
  fullname: Ilonen, J
– sequence: 9
  givenname: O
  surname: Simell
  fullname: Simell, O
– sequence: 10
  givenname: M
  surname: Knip
  fullname: Knip, M
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16779702$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/15872335$$D View this record in MEDLINE/PubMed
BookMark eNqFkU9v0zAYxi00xLrBjTPyBU7LsOPETo9VBxtSJdDYAU6W67xZ3CZ25z-q-oH4nnPUil2QsGX58nue57WfC3RmnQWE3lNyTUtKPm_0dUlIVVAm6Cs0o_OqLgSdizM0I6SkxVyUv87RRQgbQmhV1ewNOqd1I0rG6hn6c3OwajQ6YNfhG6PWECEUixCcNipCixcpOmWjWbvWQMDG4t8u2Ue87M3QerB4b2KP79KoLF5B2jp9iIAXWfEItlg624H32efehO2U8XDYAaZ_o_A9aJ_MlNR5N-LYA74FC14N-IfbpUFF4-xb9LpTQ4B3p_sS_fz65WF5V6y-335bLlaFroTghWK6XnOuBGFC1C1rKlJRUreCU6pUy3nHmjkRHc94pwlvGeh1KbSoSFuX7BJ9OrruvHtKEKIcTdAwDMqCS0FyIeYNpeS_IBWMZU-WwasjqL0LwUMnd96Myh8kJXJqT260nNqTU3sZ_3DyTesR2hf4VFcGPp4AFbQaOq-sNuGFmyYUZHpJdeT2bojgw3ZIe_CyBzXEXpK8Ki6aIifXeRNS5MN4lrGjDGzrtDcWdh5CkBuXvM3__u-pnwE9wsXc
CODEN JCEMAZ
CitedBy_id crossref_primary_10_2337_db11_0386
crossref_primary_10_2337_dc14_2426
crossref_primary_10_1016_j_autrev_2008_04_008
crossref_primary_10_1056_NEJMoa1004809
crossref_primary_10_3181_0701_RM_13
crossref_primary_10_1002_sim_9190
crossref_primary_10_1097_MPG_0b013e31805fc256
crossref_primary_10_1111_j_1399_5448_2011_00783_x
crossref_primary_10_2337_diabetes_54_suppl_2_S125
crossref_primary_10_1016_j_jaut_2015_05_005
crossref_primary_10_2337_dc15_1027
crossref_primary_10_1210_clinem_dgaa624
crossref_primary_10_1007_s00125_017_4258_7
crossref_primary_10_1111_j_1399_5448_2012_00917_x
crossref_primary_10_2337_db10_0186
crossref_primary_10_1111_cei_13391
crossref_primary_10_1016_j_diabet_2010_10_002
crossref_primary_10_12968_bjon_2016_25_6_330
crossref_primary_10_1515_jpem_2016_0030
crossref_primary_10_1017_S0007114520000744
crossref_primary_10_1016_S0140_6736_13_60591_7
crossref_primary_10_5812_jpr_157
crossref_primary_10_1097_01_med_0000235329_84906_3b
crossref_primary_10_1017_S0007114513003073
crossref_primary_10_1111_pedi_12329
crossref_primary_10_1007_s00592_014_0673_0
crossref_primary_10_3389_fimmu_2022_909020
crossref_primary_10_1111_apm_12023
crossref_primary_10_12968_pnur_2017_28_1_28
crossref_primary_10_1111_j_1399_5448_2008_00369_x
crossref_primary_10_1111_j_1399_5448_2008_00398_x
crossref_primary_10_1016_j_jaut_2008_04_024
crossref_primary_10_1007_s00125_017_4410_4
crossref_primary_10_1007_s00428_021_03055_z
crossref_primary_10_1210_jc_2019_01069
crossref_primary_10_2337_dc09_1217
crossref_primary_10_1056_NEJMc1100063
crossref_primary_10_1155_2012_457546
crossref_primary_10_3389_fmicb_2014_00361
crossref_primary_10_1016_S1155_1941_07_46585_4
crossref_primary_10_1007_s11892_012_0310_7
crossref_primary_10_1007_s00125_006_0225_4
crossref_primary_10_1016_j_coi_2005_09_013
crossref_primary_10_1111_pedi_12697
crossref_primary_10_1002_dmrr_998
crossref_primary_10_3390_ijms22147493
crossref_primary_10_1089_dia_2021_0554
crossref_primary_10_1016_j_dsx_2012_08_006
crossref_primary_10_2337_dc06_0711
crossref_primary_10_1016_S0140_6736_08_61309_4
crossref_primary_10_1007_s00125_016_4177_z
crossref_primary_10_3109_08916934_2015_1134509
crossref_primary_10_1007_s00125_010_1734_8
crossref_primary_10_2337_dc07_1457
crossref_primary_10_1111_pedi_12023
crossref_primary_10_1111_pedi_12386
crossref_primary_10_2337_db13_0620
crossref_primary_10_1038_ejcn_2010_75
crossref_primary_10_1530_EJE_15_0674
crossref_primary_10_1016_j_cellimm_2011_12_008
crossref_primary_10_1007_s00281_017_0665_6
crossref_primary_10_1097_MPG_0000000000001293
crossref_primary_10_1016_j_jcyt_2016_06_006
crossref_primary_10_1007_s00125_008_1107_8
crossref_primary_10_1111_j_1399_5448_2008_00415_x
Cites_doi 10.1111/j.1399-0004.1984.tb01100.x
10.1038/371130a0
10.1126/science.3287615
10.1007/s00125-002-0949-8
10.1111/j.1365-2362.1996.tb02126.x
10.2337/diabetes.48.3.460
10.2337/diab.43.7.843
10.1006/jaut.1997.0154
10.1210/jc.2002-020018
10.2337/diab.41.12.1570
10.1016/S0140-6736(74)90140-8
10.3109/07853899708999375
10.1046/j.1464-5491.1999.00186.x
10.1007/s001250051067
10.1016/S0140-6736(01)05415-0
10.1007/s001250050925
10.2337/diabetes.50.11.2625
10.1172/JCI14257
10.2337/diabetes.51.3.646
10.2337/diacare.22.12.2049
10.1007/s001250051616
ContentType Journal Article
Copyright Copyright © 2005 by The Endocrine Society
2005 INIST-CNRS
Copyright_xml – notice: Copyright © 2005 by The Endocrine Society
– notice: 2005 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7TS
H94
7X8
DOI 10.1210/jc.2004-1371
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
Physical Education Index
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
Immunology Abstracts
Physical Education Index
MEDLINE - Academic
DatabaseTitleList MEDLINE

AIDS and Cancer Research Abstracts

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1945-7197
EndPage 2717
ExternalDocumentID 10_1210_jc_2004_1371
15872335
16779702
00004678-200505000-00036
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
02
08R
0R
1TH
29K
2WC
34G
39C
3O-
3V.
4.4
48X
53G
55
5GY
5RS
5YH
7X7
88E
8F7
8FI
8FJ
AABJS
AABMN
AAIMJ
AAJQQ
AAPQZ
AAQQT
AAUQX
AAWTL
AAYJJ
ABFLS
ABOCM
ABPMR
ABPPZ
ABSAR
ABUWG
ACGFS
ACIMA
ACPRK
ACUTJ
ADBBV
ADBIT
ADEIU
ADGZP
ADHKW
ADRTK
AELNO
AELWJ
AEMDU
AENEX
AENZO
AETBJ
AEWNT
AFCHL
AFFNX
AFKRA
AFRAH
AFXEN
AGINJ
AGKRT
AGVJH
AHMBA
AIKOY
AIMBJ
ALMA_UNASSIGNED_HOLDINGS
APIBT
AQKUS
ARIXL
ASMCH
ASPBG
AVWKF
AYOIW
AZFZN
AZQFJ
BAWUL
BAYMD
BBAFP
BCRHZ
BENPR
BEYMZ
BGYMP
BHONS
BPHCQ
BSWAC
BTRTY
BVXVI
C45
CDBKE
CS3
D-I
DAKXR
DIK
DPPUQ
E3Z
EBS
EIHJH
EJD
ENERS
F5P
FEDTE
FH7
FHSFR
FOTVD
FQBLK
FYUFA
G8K
GAUVT
GJ
GJXCC
GX1
H1
H13
HVGLF
HZ
H~9
IAO
IHR
INH
J5H
KBUDW
KOP
KQ8
KSN
L7B
M1P
M5
MBLQV
MHKGH
N9A
NLBLG
NOYVH
NVLIB
O0-
O9-
OBH
OCB
ODMLO
OGEVE
OK1
OVD
P2P
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
REU
ROX
ROZ
TCN
TJX
TLC
TMA
TWZ
VH1
WOQ
X
X52
X7M
XZ
ZA5
ZGI
ZXP
ZY1
.XZ
3RD
AJYGW
M2M
M5~
ROL
~H1
---
-~X
.55
.GJ
08P
0R~
18M
354
AABZA
AACZT
AAKAS
AAPGJ
AAPXW
AAUGY
AAVAP
AAWDT
ABBLC
ABLJU
ABPQP
ABPTD
ABWST
ABXZS
ACFRR
ACGFO
ACYHN
ADGKP
ADVEK
ADZCM
AERZD
AFFZL
AFGWE
AFOFC
AFXAL
AFYAG
AGQXC
AGUTN
AI.
AJEEA
ALXQX
APJGH
AQDSO
BYORX
CASEJ
EMOBN
FECEO
FLUFQ
FOEOM
HZ~
IQODW
KSI
MJL
N4W
NOMLY
OAUYM
OBFPC
OFXIZ
OHH
OPAEJ
OVIDX
P6G
TEORI
TR2
VVN
W8F
WHG
YBU
YFH
YHG
YOC
YSK
~02
AARHZ
AAUAY
ABJNI
ABMNT
ABNHQ
ABQNK
ABXVV
ACZBC
ADQBN
AGMDO
ATGXG
AVNTJ
CGR
CUY
CVF
ECM
EIF
ITC
NPM
OJZSN
AAYXX
CITATION
7T5
7TS
H94
7X8
ID FETCH-LOGICAL-c4776-a3c5b66a703775d38404105d7611aad66f38907f6c47fc06d3ecb27c740d523
ISSN 0021-972X
IngestDate Fri Aug 16 08:32:25 EDT 2024
Fri Aug 16 23:52:07 EDT 2024
Thu Sep 12 16:26:00 EDT 2024
Sat Sep 28 07:43:22 EDT 2024
Sun Oct 22 16:06:29 EDT 2023
Thu Aug 13 19:45:25 EDT 2020
Tue Jan 05 21:44:36 EST 2021
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Endocrinopathy
Human
Autoimmunity
Immunopathology
Antibody
Leukocyte
Autoantibody
Autoimmune disease
Antigen
Type 1 diabetes
Dynamics
Risk factor
Child
Endocrinology
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4776-a3c5b66a703775d38404105d7611aad66f38907f6c47fc06d3ecb27c740d523
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://academic.oup.com/jcem/article-pdf/90/5/2712/10776273/jcem2712.pdf
PMID 15872335
PQID 17337403
PQPubID 23462
PageCount 6
ParticipantIDs proquest_miscellaneous_67798110
proquest_miscellaneous_17337403
crossref_primary_10_1210_jc_2004_1371
pubmed_primary_15872335
pascalfrancis_primary_16779702
wolterskluwer_health_00004678-200505000-00036
endocrinepress_journals_10_1210_jc_2004_1371
ProviderPackageCode .XZ
OBH
C45
5RS
AFCHL
OGEVE
~H1
ABPMR
M5~
OVD
OCB
PublicationCentury 2000
PublicationDate 2005-May
PublicationDateYYYYMMDD 2005-05-01
PublicationDate_xml – month: 05
  year: 2005
  text: 2005-May
PublicationDecade 2000
PublicationPlace Bethesda, MD
PublicationPlace_xml – name: Bethesda, MD
– name: United States
PublicationTitle The journal of clinical endocrinology and metabolism
PublicationTitleAlternate J Clin Endocrinol Metab
PublicationYear 2005
Publisher Endocrine Society
Copyright by The Endocrine Society
Publisher_xml – name: Endocrine Society
– name: Copyright by The Endocrine Society
References Bottazzo (2019041115290180900_R17) 1974; 2
Thai (2019041115290180900_R1) 1993; 1
Savola (2019041115290180900_R21) 1998; 41
Ziegler (2019041115290180900_R11) 1999; 48
Kimpimäki (2019041115290180900_R10) 2000; 85
Bertrams (2019041115290180900_R5) 1984
Sjöroos (2019041115290180900_R15) 1995; 18
Kimpimäki (2019041115290180900_R13) 2002; 87
Christie (2019041115290180900_R26) 1994; 43
Notkins (2019041115290180900_R3) 2001; 108
Greenbaum (2019041115290180900_R18) 1992; 41
Kupila (2019041115290180900_R14) 2001; 44
Savola (2019041115290180900_R24) 2001; 50
Atkinson (2019041115290180900_R4) 2001; 358
Davies (2019041115290180900_R6) 1994; 371
Savola (2019041115290180900_R20) 1998; 41
Nejentsev (2019041115290180900_R16) 1999; 16
Gardner (2019041115290180900_R25) 1999; 22
Leslie (2019041115290180900_R9) 1994; 43
Swets (2019041115290180900_R22) 1988; 240
Decochez (2019041115290180900_R27) 2002; 45
Kupila (2019041115290180900_R12) 2002; 51
Knip (2019041115290180900_R2) 1997; 29
Christie (2019041115290180900_R8) 1996; 26
Rotter (2019041115290180900_R7) 1984; 26
Williams (2019041115290180900_R19) 1997; 10
Yu (2019041115290180900_R23) 2000; 85
References_xml – volume: 26
  start-page: 529
  year: 1984
  ident: 2019041115290180900_R7
  article-title: Measuring the genetic contribution of a single locus to a multilocus disease.
  publication-title: Clin Genet
  doi: 10.1111/j.1399-0004.1984.tb01100.x
  contributor:
    fullname: Rotter
– volume: 371
  start-page: 130
  year: 1994
  ident: 2019041115290180900_R6
  article-title: A genome wide search for human type I diabetes susceptibility genes.
  publication-title: Nature
  doi: 10.1038/371130a0
  contributor:
    fullname: Davies
– volume: 240
  start-page: 1285
  year: 1988
  ident: 2019041115290180900_R22
  article-title: Measuring the accuracy of diagnostic systems.
  publication-title: Science
  doi: 10.1126/science.3287615
  contributor:
    fullname: Swets
– volume: 45
  start-page: 1658
  year: 2002
  ident: 2019041115290180900_R27
  article-title: IA-2 antibodies predict impending type I diabetes in siblings of patients.
  publication-title: Diabetologia
  doi: 10.1007/s00125-002-0949-8
  contributor:
    fullname: Decochez
– volume: 43
  start-page: 1254
  year: 1994
  ident: 2019041115290180900_R26
  article-title: Antibodies to 37K antigen but not to glutamate decarboxylase discriminate rapid progression to insulin-dependent diabetes mellitus in endocrine autoimmunity.
  publication-title: Diabetologia
  contributor:
    fullname: Christie
– volume: 26
  start-page: 827
  year: 1996
  ident: 2019041115290180900_R8
  article-title: Islet cell autoantigens in type 1 diabetes.
  publication-title: Eur J Clin Invest
  doi: 10.1111/j.1365-2362.1996.tb02126.x
  contributor:
    fullname: Christie
– volume: 48
  start-page: 460
  year: 1999
  ident: 2019041115290180900_R11
  article-title: Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study.
  publication-title: Diabetes
  doi: 10.2337/diabetes.48.3.460
  contributor:
    fullname: Ziegler
– volume: 43
  start-page: 843
  year: 1994
  ident: 2019041115290180900_R9
  article-title: Perspectives in diabetes: early environmental events as a cause of IDDM: evidence and implications.
  publication-title: Diabetes
  doi: 10.2337/diab.43.7.843
  contributor:
    fullname: Leslie
– volume: 10
  start-page: 473
  year: 1997
  ident: 2019041115290180900_R19
  article-title: A novel micro-assay for insulin autoantibodies.
  publication-title: J Autoimmun
  doi: 10.1006/jaut.1997.0154
  contributor:
    fullname: Williams
– volume: 85
  start-page: 1126
  year: 2000
  ident: 2019041115290180900_R10
  article-title: Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk.
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Kimpimäki
– volume: 87
  start-page: 4572
  year: 2002
  ident: 2019041115290180900_R13
  article-title: Natural history of β-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2002-020018
  contributor:
    fullname: Kimpimäki
– volume: 41
  start-page: 1570
  year: 1992
  ident: 2019041115290180900_R18
  article-title: Improved specificity of ICA assay in the Fourth International Immunology of Diabetes Serum Exchange Workshop.
  publication-title: Diabetes
  doi: 10.2337/diab.41.12.1570
  contributor:
    fullname: Greenbaum
– volume: 85
  start-page: 2421
  year: 2000
  ident: 2019041115290180900_R23
  article-title: Transient anti-islet autoantibodies: infrequent occurrence and lack of association with “genetic” risk factors.
  publication-title: J Clin Endocrinol Metab
  contributor:
    fullname: Yu
– volume: 2
  start-page: 1279
  year: 1974
  ident: 2019041115290180900_R17
  article-title: Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(74)90140-8
  contributor:
    fullname: Bottazzo
– volume: 1
  start-page: 1
  year: 1993
  ident: 2019041115290180900_R1
  article-title: Natural history of IDDM.
  publication-title: Diabetes Rev
  contributor:
    fullname: Thai
– volume: 29
  start-page: 447
  year: 1997
  ident: 2019041115290180900_R2
  article-title: Disease-associated autoimmunity and prevention of insulin-dependent diabetes mellitus.
  publication-title: Ann Med
  doi: 10.3109/07853899708999375
  contributor:
    fullname: Knip
– start-page: 348
  year: 1984
  ident: 2019041115290180900_R5
  article-title: Insulin-dependent diabetes mellitus
  publication-title: In: Albert ED, Baur MP, Mayr WR, eds. Histocompability testing. Berlin, Heidelberg, New York: Springer-Verlag;
  contributor:
    fullname: Bertrams
– volume: 16
  start-page: 985
  year: 1999
  ident: 2019041115290180900_R16
  article-title: Population-based genetic screening for the estimation of type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci.
  publication-title: Diabet Med
  doi: 10.1046/j.1464-5491.1999.00186.x
  contributor:
    fullname: Nejentsev
– volume: 41
  start-page: 1293
  year: 1998
  ident: 2019041115290180900_R20
  article-title: Autoantibodies associated with type I diabetes mellitus persist after diagnosis in children.
  publication-title: Diabetologia
  doi: 10.1007/s001250051067
  contributor:
    fullname: Savola
– volume: 358
  start-page: 221
  year: 2001
  ident: 2019041115290180900_R4
  article-title: Type 1 diabetes: new perspectives on disease pathogenesis and treatment.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(01)05415-0
  contributor:
    fullname: Atkinson
– volume: 41
  start-page: 424
  year: 1998
  ident: 2019041115290180900_R21
  article-title: IA-2 antibodies: a sensitive marker of IDDM with clinical onset in childhood and adolescence.
  publication-title: Diabetologia
  doi: 10.1007/s001250050925
  contributor:
    fullname: Savola
– volume: 50
  start-page: 2625
  year: 2001
  ident: 2019041115290180900_R24
  article-title: Dynamic pattern of disease-associated autoantibodies in siblings of children with type 1 diabetes: a population based study.
  publication-title: Diabetes
  doi: 10.2337/diabetes.50.11.2625
  contributor:
    fullname: Savola
– volume: 108
  start-page: 1247
  year: 2001
  ident: 2019041115290180900_R3
  article-title: Autoimmune type 1 diabetes: resolved and unresolved issues.
  publication-title: J Clin Invest
  doi: 10.1172/JCI14257
  contributor:
    fullname: Notkins
– volume: 51
  start-page: 646
  year: 2002
  ident: 2019041115290180900_R12
  article-title: Genetic risk determines the emergence of diabetes-associated autoantibodies in young children.
  publication-title: Diabetes
  doi: 10.2337/diabetes.51.3.646
  contributor:
    fullname: Kupila
– volume: 22
  start-page: 2049
  year: 1999
  ident: 2019041115290180900_R25
  article-title: Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?
  publication-title: Diabetes Care
  doi: 10.2337/diacare.22.12.2049
  contributor:
    fullname: Gardner
– volume: 18
  start-page: 870
  year: 1995
  ident: 2019041115290180900_R15
  article-title: Triple-label hybridization assay for type I diabetes-related HLA alleles.
  publication-title: Biotechniques
  contributor:
    fullname: Sjöroos
– volume: 44
  start-page: 290
  year: 2001
  ident: 2019041115290180900_R14
  article-title: Feasibility of genetic and immunological prediction of type 1 diabetes in a population based cohort.
  publication-title: Diabetologia
  doi: 10.1007/s001250051616
  contributor:
    fullname: Kupila
SSID ssj0014453
Score 2.2025416
Snippet This study characterized the dynamics of islet cell antibodies (ICA), insulin antibodies (IAA), glutamic acid decarboxylase antibodies (GADA), and IA-2...
SourceID proquest
crossref
pubmed
pascalfrancis
wolterskluwer
endocrinepress
SourceType Aggregation Database
Index Database
Publisher
StartPage 2712
SubjectTerms Autoantibodies - blood
Biological and medical sciences
Child
Diabetes Mellitus, Type 1 - immunology
Endocrinopathies
Female
Fundamental and applied biological sciences. Psychology
Glutamate Decarboxylase - immunology
HLA-DQ Antigens - genetics
HLA-DQ beta-Chains
Humans
Insulin Antibodies - blood
Male
Medical sciences
Vertebrates: endocrinology
Title Dynamics of Diabetes-Associated Autoantibodies in Young Children with Human Leukocyte Antigen-Conferred Risk of Type 1 Diabetes Recruited from the General Population
URI http://dx.doi.org/10.1210/jc.2004-1371
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004678-200505000-00036
https://www.ncbi.nlm.nih.gov/pubmed/15872335
https://search.proquest.com/docview/17337403
https://search.proquest.com/docview/67798110
Volume 90
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEOIN6Ux-IDnCAoTzs9Il4rKriwSL1FjuMsoW1StYnQ8n_4Efw7ZmznxbYScImq1Jq0mc_2zPibGUKeujKMmRShoyJfYOjGdYRUnhN7ErYfgFSYa7bFJ3byJfywiBaTya8Ba6mp05fyx968kv_RKtwDvWKW7D9othMKN-Az6BeuoGG4_pWO35h28pqN0QZRHWFfOFiSoqkreHNFWiFXEEMb5zi5xxnctk3fSjXLSp7XeJxQY4lOR-pkQOSnt_xzHa_1-ngtrJbbRtusXZbKmSlj_XzTNQYbmr8IykGtii4tU5VZBctX2ReEWqsa4LlqCxzqw6blshrFb-fFelOs9VF_aLpvd4zvebX9WpVqHNydN5tiJfoAbhvsiHpqYZd84Dkzrjuwdwu46TdqgRoNV2NuKNoXtgnwc3Gb0CUsQ8cLTBeYAWI2aw0ZL4q5H5h6Kn-U5W6_ukQu-3wWIZv0_aJjF4Gbagug2t9rcy4wYWr4WN0VyggaGUbX2vdu6NDI2BU70Eduuq3sc4dgzPcKGRa7pU6wGJhJpzfIdevf0FcGrDfJRJW3yJWPlsFxm_xsMUurnO7BLB1jlhYl1ZilLWYpYpZqzNIOs_QCZiliFp-BmKVe9yjaYZYiZilgllrM0h6zd8jnd29PX584tlWII0POmSMCGaWMCdi_OI-yIA5d5C9nnHmeEBljORjmLs8ZDM-ly7JAydTnkoduFvnBXXJUAijvE6ri0OOZn2exQE8hj6OMZSxwZQqLHVfRlDxrtZRsTD2YBP1oUGzyTWJT1zBBxU7Ji7EKEzu7dgeGH48U3MtmnM-460_Jk1bjCWwAeKonSlU1II4HAfyN4PAIFBGDmT8l9wxUeukWe1PijLCTmCTsREcQwJzFVRdcJVuFImAPDkp6SK728_YROaq3jXoMZnudHusJ8hu1T_Im
link.rule.ids 315,786,790,27955,27956
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dynamics+of+diabetes-associated+autoantibodies+in+young+children+with+human+leukocyte+antigen-conferred+risk+of+type+1+diabetes+recruited+from+the+general+population&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Kukko%2C+M&rft.au=Kimpim%C3%A4ki%2C+T&rft.au=Korhonen%2C+S&rft.au=Kupila%2C+A&rft.date=2005-05-01&rft.issn=0021-972X&rft.volume=90&rft.issue=5&rft.spage=2712&rft_id=info:doi/10.1210%2Fjc.2004-1371&rft_id=info%3Apmid%2F15872335&rft.externalDocID=15872335
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon